Literature DB >> 11359129

Thyroplasty for adductor spasmodic dysphonia: further experiences.

N Isshiki1, T Haji, Y Yamamoto, H F Mahieu.   

Abstract

OBJECTIVES: Two different surgical techniques for midline lateralization thyroplasty (type 2 thyroplasty) for adductor spasmodic dysphonia (SD) have been described, one using a composite graft and the other without. Indications and results for each method among different types of SD were compared, together with the theoretical background for the surgery. STUDY
DESIGN: Retrospective.
METHODS: The medical records of six patients with SD together with the fiberscopic video recording of laryngeal findings before, during, and after surgery were reviewed. The intraoperative video recordings of the surgical procedures were compared with the postoperative findings.
RESULTS: The vocal features of SD, diverse preoperatively, disappeared postoperatively and a normal, or almost normal, voice was attained in 5 of 6 cases. The failure in one patient was attributed to combined focal dystonia of the neck muscles and difficulty in lateralization. Type 2 thyroplasty without a graft, which causes bowing of both vocal folds, is simple to perform and effective enough for most SD cases. No recurrence has been noted so far over postoperative periods ranging from 6 months to more than 3 years.
CONCLUSION: The results suggest that thyroplasty is an effective therapeutic approach for SD.

Entities:  

Mesh:

Year:  2001        PMID: 11359129     DOI: 10.1097/00005537-200104000-00011

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  9 in total

Review 1.  ["Off-label use" of botulinum toxin preparations in treatment of spasmodic dysphonia. Position of the German Society of Phoniatrics and Pediatric Audiology].

Authors:  M Ptok; R Schönweiler; T Nawka
Journal:  HNO       Date:  2004-01       Impact factor: 1.284

2.  Validity of intraoperative voice monitoring undergoing type 2 thyroplasty with titanium bridges for adductor spasmodic dysphonia.

Authors:  Tetsuji Sanuki; Nobuhiko Oridate; Ichiro Tateya; Takaharu Nito; Kenji Mizoguchi; Kenichiro Tanabe
Journal:  Laryngoscope Investig Otolaryngol       Date:  2022-08-22

3.  SURGICAL MANAGEMENT OF VOCAL CORD PARALYSIS: THE NEED FOR CAREFUL PATIENT SELECTION.

Authors:  D D Kokong; A A Adoga; A Bakari; P O Okundia; P A Onakoya; Ogb Nwaorgu
Journal:  Afr J Med Med Sci       Date:  2014-09

4.  Evaluation of type II thyroplasty on phonatory physiology in an excised canine larynx model.

Authors:  Erin E Devine; Matthew R Hoffman; Timothy M McCulloch; Jack J Jiang
Journal:  Laryngoscope       Date:  2016-05-25       Impact factor: 3.325

5.  Botulinum toxin injection into the intrinsic laryngeal muscles to treat spasmodic dysphonia: A multicenter, placebo-controlled, randomized, double-blinded, parallel-group comparison/open-label clinical trial.

Authors:  Masamitsu Hyodo; Asuka Nagao; Kento Asano; Masahiko Sakaguchi; Kenji Mizoguchi; Koichi Omori; Yasuhiro Tada; Hiromitsu Hatakeyama; Nobuhiko Oridate; Kensei Naito; Yoshihiro Iwata; Hirotaka Shinomiya; Hirotaka Hara; Tetsuji Sanuki; Eiji Yumoto
Journal:  Eur J Neurol       Date:  2021-01-23       Impact factor: 6.089

6.  Post-treatment clinical course following botulinum toxin injection therapy for adductor spasmodic dysphonia: Analysis of data from a placebo-controlled, randomized, double-blinded clinical trial in Japan.

Authors:  Kahori Hirose; Kento Asano; Masahiko Sakaguchi; Asuka Nagao; Maya Nakahira; Nao Doi; Taisuke Kobayashi; Masamitsu Hyodo
Journal:  Laryngoscope Investig Otolaryngol       Date:  2021-09-28

Review 7.  Botulinum Toxin Therapy for Spasmodic Dysphonia in Japan: The History and an Update.

Authors:  Masamitsu Hyodo; Kahori Hirose; Asuka Nagao; Maya Nakahira; Taisuke Kobayashi
Journal:  Toxins (Basel)       Date:  2022-07-01       Impact factor: 5.075

Review 8.  Treatment for spasmodic dysphonia: limitations of current approaches.

Authors:  Christy L Ludlow
Journal:  Curr Opin Otolaryngol Head Neck Surg       Date:  2009-06       Impact factor: 1.814

Review 9.  Botulinum Toxin Therapy: A Series of Clinical Studies on Patients with Spasmodic Dysphonia in Japan.

Authors:  Masamitsu Hyodo; Kento Asano; Asuka Nagao; Kahori Hirose; Maya Nakahira; Saori Yanagida; Noriko Nishizawa
Journal:  Toxins (Basel)       Date:  2021-11-25       Impact factor: 4.546

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.